{"id":"https://openalex.org/W2392435592","doi":null,"title":"The Short-term Therapeutic Effect of Cetuximab Plus FOLFIRI Versus FOLFIRI Alone in the Treatment of Patients with Metastatic Colorectal Cancer","display_name":"The Short-term Therapeutic Effect of Cetuximab Plus FOLFIRI Versus FOLFIRI Alone in the Treatment of Patients with Metastatic Colorectal Cancer","alternate_titles":[],"publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2392435592","mag":"2392435592"},"language":"en","primary_location":{"id":"mag:2392435592","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=SWCX201210026","pdf_url":null,"source":{"id":"https://openalex.org/S2764952023","display_name":"Xiandai shengwu yixue jinzhan","issn_l":"1673-6273","issn":["1673-6273"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4361727479","host_organization_name":"Heilongjiang Red Cross Society","host_organization_lineage":["https://openalex.org/P4361727479"],"host_organization_lineage_names":["Heilongjiang Red Cross Society"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Xiandai shengwu yixue jinzhan","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2392435592"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101746989","display_name":"Dai Guang-hai","orcid":"https://orcid.org/0009-0008-7190-1515","observed_orcids":["https://orcid.org/0009-0008-7190-1515","https://orcid.org/0000-0001-6567-2594"]},"institutions":[{"id":"https://openalex.org/I2802939634","display_name":"Chinese PLA General Hospital","ror":"https://ror.org/04gw3ra78","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802939634"]}],"countries":["CN"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Dai Guang-hai","raw_affiliation_strings":["Department of multimodality therapy of oncology,PLA General Hospital,Beijing 100853,China)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of multimodality therapy of oncology,PLA General Hospital,Beijing 100853,China)","institution_ids":["https://openalex.org/I2802939634"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5101746989"],"corresponding_institution_ids":["https://openalex.org/I2802939634"],"apc_list":null,"apc_paid":null,"fwci":0.3036,"has_fulltext":false,"cited_by_count":2,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.59166215,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":92},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9909999966621399},{"id":"https://openalex.org/keywords/folfiri","display_name":"FOLFIRI","score":0.9990000128746033},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/kras-wild-type","display_name":"KRAS wild-type","score":0.8399999737739563},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7239999771118164},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.8009999990463257},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.5590000152587891},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.4480000138282776}],"concepts":[{"id":"https://openalex.org/C2776705615","wikidata":"https://www.wikidata.org/wiki/Q1389369","display_name":"FOLFIRI","level":5,"score":0.9689936637878418},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.8934776782989502},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8546571731567383},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.7697049379348755},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6531063914299011},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5981141328811646},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5919026732444763},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5431903600692749},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.41832858324050903},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4181053638458252},{"id":"https://openalex.org/C2777299880","wikidata":"https://www.wikidata.org/wiki/Q413370","display_name":"Tegafur","level":3,"score":0.41401544213294983},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.39402925968170166},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.3868102729320526}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2392435592","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=SWCX201210026","pdf_url":null,"source":{"id":"https://openalex.org/S2764952023","display_name":"Xiandai shengwu yixue jinzhan","issn_l":"1673-6273","issn":["1673-6273"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4361727479","host_organization_name":"Heilongjiang Red Cross Society","host_organization_lineage":["https://openalex.org/P4361727479"],"host_organization_lineage_names":["Heilongjiang Red Cross Society"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Xiandai shengwu yixue jinzhan","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2356199669","https://openalex.org/W2588171981","https://openalex.org/W2394070723","https://openalex.org/W2095201384","https://openalex.org/W2131183275","https://openalex.org/W2374705172","https://openalex.org/W2376570677","https://openalex.org/W2599421998","https://openalex.org/W2159744025","https://openalex.org/W2809074760"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"investigate":[2],"the":[3,17,39,122,140],"clinical":[4],"efficacy":[5,70,89,113],"and":[6,14,58,71,85,110,139],"toxicity":[7,72,132],"of":[8,19,68,79,90,104,114],"two":[9,81,135],"regimens,cetuximab":[10],"combined":[11,45,92,116],"with":[12,21,32,46,93,117,128],"FOLFIRI":[13,15,47,59,94,99,118],"alone,in":[16],"treatment":[18],"patients":[20,57,106,127],"metastatic":[22,33,129],"colorectal":[23,34,130],"cancer.Methods:":[24],"From":[25],"Jan":[26],"2008":[27],"to":[28],"Nov":[29],"2011,46":[30],"cases":[31],"cancer":[35],"were":[36,83,107],"studied":[37],"retrospectively.All":[38],"diagnosis":[40],"was":[41,49,62,73,95],"confirmed":[42],"by":[43],"histopathology.Cetuximab":[44],"regimen":[48,61],"performed":[50,63],"in":[51,64],"22":[52],"K-Ras":[53,123],"gene":[54,124],"wild":[55,125],"type":[56,126],"alone":[60],"24":[65],"patients.The":[66],"data":[67],"therapeutic":[69,88],"analyzed.Results:":[74],"The":[75,112],"objective":[76],"response":[77],"rate(CR+PR)":[78],"these":[80,105,134],"groups":[82,136],"41.6%":[84],"12.5%":[86],"respectively,the":[87],"cetuximab":[91,115],"significantly":[96],"higher":[97],"than":[98],"alone(P0.05).The":[100],"mainly":[101],"adverse":[102,141],"reactions":[103],"exanthems,diarrhea,marrow":[108],"suppression,nausea":[109],"alopecia.Conclusion:":[111],"is":[119,137],"significant":[120],"for":[121],"cancer.The":[131],"between":[133],"similar":[138],"effects":[142],"are":[143],"tolerable.":[144]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2392435592","counts_by_year":[{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
